Between October 18–21, this website will move to a new web address (from health.gov to odphp.health.gov). During that time, some functions might not work as expected. We appreciate your patience and understanding as we’re working to make this transition as smooth as possible.

Reduce severe maternal complications identified during delivery hospitalizations — MICH‑05 Data Methodology and Measurement

About the National Data

Data

Baseline: 71.5 per 10,000 delivery hospitalizations had severe maternal complications in 2017

Target: 64.4 per 10,000

Numerator
Number of hospital discharges for females with any listed diagnosis or procedure indicating severe maternal complications (excluding blood transfusions).
Denominator
Number of hospital discharges for females aged 12 to 55 years who delivered one or more infants.
Target-setting method
Percent improvement
Target-setting method details
10 percent improvement from the baseline.
Target-setting method justification
Although trend data are now available for this objective, the projected trend is opposite our desired target. Therefore, a 10% improvement from the baseline was used to calculate a target which is consistent with prior stated objectives for this outcome.

Methodology

Methodology notes

This measure originally followed the CDC-developed definition of severe maternal morbidity identified from hospital discharge procedure and diagnosis codes that indicate a potentially life-threatening condition or maternal complication (Callaghan et al, 2012). Specific ICD-9-CM diagnosis and procedure codes had been reduced to 21 indicators (18 if 3 are collapsed) in preparation for the transition to ICD-10-CM and described in detail by the National Center for Chronic Disease Prevention and Health Promotion, CDC. The transition from ICD-9-CM to ICD-10-CM/PCS coding of hospital discharge information required a re-alignment of the SMM algorithm. CDC, HRSA and AHRQ collaborated to produce the revised definition used for Healthy People 2030.

With the exception of hospitalizations with in-hospital mortality, transfer, or severe complications identified by procedure codes (e.g., hysterectomy, blood transfusion, ventilation), cases of severe maternal morbidity identified by diagnostic codes were reclassified as hospitalizations without severe maternal morbidity if they had an implausibly short length of stay (≤ 3 days for vaginal,<4 days for primary cesarean, and < 5 days for repeat cesarean deliveries). Delivery hospitalizations were identified by diagnosis codes for an outcome of delivery, diagnosis-related group delivery codes, and procedure codes for selected delivery-related procedures (Kuklina et al, 2008).

Although blood transfusions are significant maternal health events and can be an indicator of SMM, they may not always reflect SMM in the absence of other indicators. As a result of this and changes in data reporting, SMM estimates provided here do not include those who only received blood transfusions.

The HCUP-NIS data represent 97% of inpatient discharges from community hospitals and do not include all states.

History

Comparable HP2020 objective
Modified, which includes core objectives that are continuing from Healthy People 2020 but underwent a change in measurement.
Changes between HP2020 and HP2030
This objective differs from Healthy People 2020 objective MICH-6 in that objective MICH-6 used data from the National Hospital Discharge Survey (NHDS - which is no longer conducted) to track maternal complications, while this objective uses data from the Healthcare Cost and Utilization Project-Nationwide Inpatient Sample (HCUP-NIS) to track severe maternal morbidities.
Revision History
Revised. 

In 2023, the baseline was revised from 68.7 per 10,000 labor and delivery hospitalizations to 71.5 per 10,000 labor and delivery hospitalizations. The target was revised from 61.8 per 10,000 to 64.4 per 10,000 due to changes in methodology.


References

Additional resources about the objective

  • American College of Obstetricians and Gynecologists and the Society for Maternal–Fetal Medicine, Kilpatrick SK, Ecker JL. Severe maternal morbidity: screening and review. Am J Obstet Gynecol. 2016 Sep;215(3):B17-22. doi: 10.1016/j.ajog.2016.07.050. Epub 2016 Aug 22. PMID: 27560600.
  • Martin JA, Hamilton BE, Osterman MJK, Driscoll AK, Matthews TJ. Births: Final data for 2015. National vital statistics report; vol 66, no 1. Hyattsville, MD: National Center for Health Statistics. 2017.
  • Hinkle SN, Sharma AJ, Kim SY, Park S, Dalenius K, Brindley PL, Grummer-Strawn LM. Prepregnancy obesity trends among low-income women, United States, 1999-2008. Matern Child Health J. 2012 Oct;16(7):1339-48. doi: 10.1007/s10995-011-0898-2. PMID: 22009444.
  • Fisher SC, Kim SY, Sharma AJ, Rochat R, Morrow B. Is obesity still increasing among pregnant women? Prepregnancy obesity trends in 20 states, 2003-2009. Prev Med. 2013 Jun;56(6):372-8. doi: 10.1016/j.ypmed.2013.02.015. Epub 2013 Feb 27. PMID: 23454595; PMCID: PMC4424789.
  • Campbell KH, Savitz D, Werner EF, Pettker CM, Goffman D, Chazotte C, Lipkind HS. Maternal morbidity and risk of death at delivery hospitalization. Obstet Gynecol. 2013 Sep;122(3):627-33. doi: 10.1097/AOG.0b013e3182a06f4e. PMID: 23921870.
  • Small MJ, James AH, Kershaw T, Thames B, Gunatilake R, Brown H. Near-miss maternal mortality: cardiac dysfunction as the principal cause of obstetric intensive care unit admissions. Obstet Gynecol. 2012 Feb;119(2 Pt 1):250-5. doi: 10.1097/AOG.0b013e31824265c7. PMID: 22270275.
  • Barber EL, Lundsberg LS, Belanger K, Pettker CM, Funai EF, Illuzzi JL. Indications contributing to the increasing cesarean delivery rate. Obstet Gynecol. 2011 Jul;118(1):29-38. doi: 10.1097/AOG.0b013e31821e5f65. PMID: 21646928; PMCID: PMC3751192.
  • Callaghan WM, Creanga AA, Kuklina EV. Severe maternal morbidity among delivery and postpartum hospitalizations in the United States. Obstet Gynecol. 2012 Nov;120(5):1029-36. doi: 10.1097/aog.0b013e31826d60c5. PMID: 23090519.